Table 1 Characteristics of patients with... | American Society of Hematology

Table 1

Characteristics of patients with adult LCH

UPN	Age, years	Gender	Organ involvement	Risk	Activity	Treatment	BRAF-V600E immunohistostaining	BRAF-V600E (%)*
1	56	F	Multi	High	Inactive	Completed	N/A	0
2	38	F	Single	High	Inactive	Completed	N/A	0
3	65	F	Multi	High	Active	Interrupted	Positive	2.59 ± 0.21
4	48	M	Single	High	Inactive	During	N/A	0
5	41	F	Single	High	Inactive	During	N/A	0
6	28	M	Multi	High	Inactive	During	N/A	0
7	29	M	Multi	High	Active	Not started	Negative	1.00 ± 0.28
8	47	F	Multi	High	Active	Interrupted	N/A	6.16 ± 0.33

UPN	Age, years	Gender	Organ involvement	Risk	Activity	Treatment	BRAF-V600E immunohistostaining	BRAF-V600E (%)*
1	56	F	Multi	High	Inactive	Completed	N/A	0
2	38	F	Single	High	Inactive	Completed	N/A	0
3	65	F	Multi	High	Active	Interrupted	Positive	2.59 ± 0.21
4	48	M	Single	High	Inactive	During	N/A	0
5	41	F	Single	High	Inactive	During	N/A	0
6	28	M	Multi	High	Inactive	During	N/A	0
7	29	M	Multi	High	Active	Not started	Negative	1.00 ± 0.28
8	47	F	Multi	High	Active	Interrupted	N/A	6.16 ± 0.33

F, female; M, male; N/A, not available; UPN, unique patient number.

Mean ± standard error.